4.4 Article

Antiplatelet antibody predicts platelet desialylation and apoptosis in immune thrombocytopenia

Related references

Note: Only part of the references are listed.
Article Hematology

Anti-glycoprotein antibodies and sequestration pattern of indium-labeled platelets in immune thrombocytopenia

Sufia N. Amini et al.

Summary: This study investigated the association between anti-GP antibodies and platelet sequestration patterns and clearance rate in ITP patients. The results showed that anti-GPV antibodies are associated with a splenic sequestration pattern, and in patients where antibodies were present, the clearance rate was higher in patients with a splenic sequestration.

BLOOD ADVANCES (2022)

Article Hematology

Autoantibody-mediated desialylation impairs human thrombopoiesis and platelet lifespan

Irene Marini et al.

Summary: In this study, novel effector functions of autoantibodies in patients with immune thrombocytopenia were identified, which interfere with the clinical presentation of the disease by inducing cleavage of sialic acid residues from the surface of platelets and megakaryocytes. Additionally, desialylation mediated by autoantibodies disrupts the interaction between cells and extracellular matrix proteins, leading to impaired platelet adhesion and megakaryocyte differentiation. This suggests that prevention of desialylation may be a potential therapeutic approach in the future clinical studies for treating bleeding in immune thrombocytopenia.

HAEMATOLOGICA (2021)

Article Pathology

Indirect detection of anti-platelet antibodies in immune thrombocytopenia

Shiying Silvia Zheng et al.

Summary: Despite recent advances in understanding and treating immune thrombocytopenia (ITP), diagnosis remains clinical due to the lack of sensitive laboratory tests. Detection of anti-platelet antibodies (APA) in plasma, although highly specific, is notoriously insensitive. By evaluating multiple dilutions of plasma from 61 ITP patients, researchers found that using just two dilutions (1:2 and 1:25) could detect over 90% of patients with detectable plasma APA, improving the diagnostic value of indirect APA assay for ITP.

PATHOLOGY (2021)

Review Hematology

Immune Thrombocytopenia: Recent Advances in Pathogenesis and Treatments

Sylvain Audia et al.

Summary: Immune thrombocytopenia (ITP) is a rare autoimmune disease characterized by peripheral destruction of platelets and inappropriate bone marrow production. The pathogenesis involves a loss of immune tolerance, leading to stimulation of autoreactive B cells by T follicular helper cells, ultimately resulting in the production of antiplatelet antibodies. Treatment strategies targeting B cells and thrombopoietin-receptor agonists have been used for years, with new emerging therapies focusing on inhibiting Fc gamma R signaling, the neonatal Fc receptor, or the classical complement pathway to potentially revolutionize ITP management.

HEMASPHERE (2021)

Article Hematology

Acquired Glanzmann thrombasthenia associated with platelet desialylation

Shiying Silvia Zheng et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)

Review Hematology

An update on the pathophysiology of immune thrombocytopenia

John W. Semple et al.

CURRENT OPINION IN HEMATOLOGY (2020)

Article Multidisciplinary Sciences

Multiple concomitant mechanisms contribute to low platelet count in patients with immune thrombocytopenia

Matias Grodzielski et al.

SCIENTIFIC REPORTS (2019)

Article Hematology

Detection of platelet autoantibodies to identify immune thrombocytopenia: state of the art

Leendert Porcelijn et al.

BRITISH JOURNAL OF HAEMATOLOGY (2018)

Review Immunology

Emerging Concepts in Immune Thrombocytopenia

Maurice Swinkels et al.

FRONTIERS IN IMMUNOLOGY (2018)

Review Medicine, General & Internal

Pathogenesis and Therapeutic Mechanisms in Immune Thrombocytopenia (ITP)

Anne Zufferey et al.

JOURNAL OF CLINICAL MEDICINE (2017)

Article Medicine, General & Internal

Pathogenesis of immune thrombocytopenia

Douglas B. Cines et al.

PRESSE MEDICALE (2014)

Article Hematology

Platelet apoptosis in paediatric immune thrombocytopenia is ameliorated by intravenous immunoglobulin

Jeannine Winkler et al.

BRITISH JOURNAL OF HAEMATOLOGY (2012)

Review Oncology

Paraneoplastic autoimmune thrombocytopenia in solid tumors

Maria-Theresa Krauth et al.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2012)

Review Hematology

The ITP syndrome: pathogenic and clinical diversity

Douglas B. Cines et al.

BLOOD (2009)

Article Hematology

Epidemiology of immune thrombocytopenic purpura in the General Practice Research Database

W. Marieke Schoonen et al.

BRITISH JOURNAL OF HAEMATOLOGY (2009)

Article Oncology

Immune Thrombocytopenia in Patients with Connective Tissue Disorders and the Antiphospholipid Antibody Syndrome

Daniel G. Arkfeld et al.

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2009)

Article Biochemistry & Molecular Biology

Dual roles for hepatic lectin receptors in the clearance of chilled platelets

Viktoria Rumjantseva et al.

NATURE MEDICINE (2009)

Article Biochemistry & Molecular Biology

Bcl-2 family proteins are essential for platelet survival

H. Zhang et al.

CELL DEATH AND DIFFERENTIATION (2007)

Article Hematology

Abnormality of CD4+CD25+ regulatory T cells in idiopathic thrombocytopenic purpura

Bin Liu et al.

EUROPEAN JOURNAL OF HAEMATOLOGY (2007)

Article Hematology

Prevalence of immune thrombocytopenia: analyses of administrative data

J. B. Segal et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)

Article Hematology

Cell-mediated lysis of autologous platelets in chronic idiopathic thrombocytopenic purpura

F Zhang et al.

EUROPEAN JOURNAL OF HAEMATOLOGY (2006)

Article Biochemistry & Molecular Biology

T-cell-mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpura

B Olsson et al.

NATURE MEDICINE (2003)